samedan logo
home > pmps > summer 2011 > roll up, roll up
Pharmaceutical Manufacturing and Packing Sourcer

Roll up, Roll up

PMPS: As one of the biggest shows in the pharmaceutical calendar, exactly what goes into producing such a huge event?

Haf Cennydd: One of the fundamental decisions that we need to make when planning the events is location. Our clients’ preference for an October date, combined with the size of the events, the number of exhibitors and the range of conferences, means that only a few cities and suitable venues are realistically available to us. When selecting a venue, the availability of hotel rooms with a sufficient scope in quality and price is essential, and facilities must be within 50km of the venue. For example,when we last held the events in Frankfurt three years ago, our exhibitors, visitors and contractors occupied over 28,000 hotel rooms. Due to the international nature of the events, travel time from the airport to the venue and visa requirements are also taken into consideration. We continually monitor feedback from both visitors and exhibitors, and look to add or adapt event content according to their input and current market trends. By doing this we ensure that we keep the events highly relevant and that our clients’ visits provide maximum return on investment.

PMPS: The show has a range of new exhibitions and zones this year, such as InnoPack. What have been the driving factors behind their creation?

HC:We introduced the zones last year in response to exhibitor and visitor feedback, to facilitate navigation of the events and help our visitors to easily find exactly what they are looking for. In 2010, ICSE featured two new zones: the Clinical Trials and Contract Research Organisation Zone and the Packaging Zone.The Clinical Trials and CRO Zone will return this year and will be accompanied by zones for New Exhibitors, a US Zone, a Logistics and Supply Chain Zone and a BioPh pavilion, as well as the General Floor. Such was the success of the Packaging Zone last year that we have launched the first ever InnoPack event for 2011, focused on innovative packaging concepts in the pharmaceutical packaging market.We already have over 90 confirmed global exhibitors, spanning Europe, Asia and the US, representing a wide range of pharmaceutical packaging sectors including materials, closures, labelling and anti-counterfeiting printing and software. CPhI will again feature zones covering APIs, custom manufacturing, intermediates, fine chemicals, excipients and general, while two new zones have been added focusing on generic APIs and finished dosage. Also P-MEC Europe will see the introduction of a LABWorld pavilion this year for laboratory, analytical and biotechnological instrumentation.

PMPS: What topics are being featured in the preshow conference, and who is speaking?

HC: The third annual ‘Global Sourcing and Contracting Strategies’ conference will be split into six modules along two tracks, each containing an expert lineup of speakers providing specialist insight and opinion. The three sessions in Track A will cover ‘Global API Sourcing Strategies’, ‘Contract Partnership Selection – CRO, CMO and CRAMS’ and ‘Supplier and Partnership Management in the Growth and Pharmerging Markets.’Track B’s sessions will focus on ‘The Strategic and Operational Future of the Pharmaceutical Industry’, ‘The Challenges and Opportunities in Biosimilars and Biobetters’ and ‘Analysing Market Growth in Generics and Super Generics’. Among the prestigious list of speakers are: Kristof Szent-Ivanyi, Director, Global Bulk Sales, GlaxoSmithKline; Thomas Niemeyer, Global External Supply Lead, Pfizer; and Hairong Zhou, SMPS Sourcing, Genentech, Roche. Once the events open, InnoPack will also feature daily ‘Innovation Briefs’ to cover on-trend topics in the packaging industry such as sustainability, packaging design for patient compliance, and so on.

PMPS: How has social media shaped the organisation and promotion of this year’s show?

HC: We use social media to keep our audience up-to-date on event developments, such as when preregistration opens or when the exhibitor list goes live. During the event, we use social media to keep our audience informed on ‘hot issues’ taking place on the show floor such as Speakers Corners, Innovation Awards and news announcements. We also post relevant industry news articles, reports and other topical information. The social media group is used all year round by our exhibitors and visitors to make and maintain connections and this further facilitates networking.

PMPS: What developments can we expect to see over the coming years, and what do you think ICSE 2021 will look like?

HC:We will continue to evolve our events and tailor them to our target audiences in order to ensure that they remain the most relevant and cuttingedge in the pharma industry calendar. A reflection of the way in which we respond to audience feedback and market trends is the introduction of BioPh for the burgeoning biopharmaceutical sector in 2009 and the launch of InnoPack this year in order to cater for the increasingly sophisticated and innovative pharmaceutical packaging market. In terms of ICSE, we expect to see more exhibitors coming from countries such as India and China as this is an on-going trend within the outsourcing of pharmaceutical contract services. Increasingly, as travel budgets and time constraints dictate, we will look to introduce virtual events across our brands to complement our physical events. Our first virtual event, CPhI Pre-Connect on September 8th, will cater for the CPhI Worldwide audience and will give attendees and those addressing them a chance to maximise networking time and make connections before the physical event in Frankfurt. CPhI Pre-Connect will feature a content-rich seminar area, networking lounges discussing cutting-edge pharma industry topics, private chats, a social media suite and much more. Our second virtual event, titled “Pharmaceutical Track and Trace Authentication: The Fight against Fake Drugs,” will take place on September 13th from 12:00 to 20:00 CET, 11:00 to 19:00 GMT and 6am to 2:00pm East Coast. Presented by UBM brands InnoPack, Pharmapack and PMP News in association with CPhI Conferences, it will include resources for buyers and sellers of technologies and services that address, among other areas, track and trace applications, authentication, labelling and coding, tamper evidence and automatic identification. The online format will offer a lineup of keynote speakers from the European Federation of Pharmaceutical Industries and Associations (EFPIA) on a major track and trace pilot in Europe, EDQM – Department for Biological Standardisation and RX360 to name a few, as well as supplier webinars with a tradeshow-like set-up, in two ‘exhibition halls’.

PMPS: CPhI is expanding around the world, with events in locations such as India and South America. Where do you plan to go next and why?

HC: We continue to monitor emerging markets and look at the possibilities of holding the pharma events portfolio in new locations. Additionally, we will look to roll out individual brands where appropriate and have recently launched a Biologics conference in partnership with Informex in the US.

PMPS: Do you have any recommendations for first-time visitors to the show?

HC: Firstly, we would advise all visitors to pre-register via the event websites in order to ensure free entrance. Due to the size of the events, we would recommend that visitors pre-schedule meetings where possible in advance of the show and have a plan of the companies that they intend to visit before they come on site, in order to maximise the productivity and value of their visit. We’d also recommend first time visitors to attend the pre-show conference, the Speakers Corners and the lunchtime educational sessions to learn about the latest industry trends and to network with their peers. Finally, as last year’s events attracted over 28,500 attendees, we would also recommend that visitors requiring overnight accommodation book their hotels early to ensure that they find somewhere convenient for travel to Messe Frankfurt.

PMPS: After a day at the exhibition, what cultural delights does the city of Frankfurt have to offer?

HC: Frankfurt is a city rich in history and culture and is always a popular venue for our exhibitors and visitors. Frankfurter Roemer (Frankfurt Romans) is Frankfurt’s famous city hall, and has existed on the site since 1405. This historic building remains the defining symbol of the city’s historic past, while the Senckenberg Natural History Museum boasts a fantastic display of dinosaurs from tiny trilobites to a T-Rex. The beautiful Palmengarten is a superb botanical garden, and for spectacular 360º views of the city, The Main Tower, at 200 metres, is ideal for a relaxing cocktail.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

Haf Cennydd is the Global Brand Director for the ICSE, InnoPack, P-MEC and BioPh events for UBM Live, a division of UBM Plc. Her role encompasses the strategy, planning and operations of these pharmaceutical events throughout the world. Haf came to UBM in 2006 and spent time as an Events Director before being promoted into this position in late 2009. Haf holds a Bachelor of the Arts, with honours, in Modern Languages and Linguistics from the Manchester Metropolitan University. Email:
Haf Cennydd
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cerba Research and ACT Genomics Announce Strategic Joint Venture — CerbACT Asia

This expansion of the precision medicine offering includes central labs, flow cytometry, histopathology, and translational science laboratory services. Deep scientific expertise from both sides of this strategic alliance will support new growth areas for biotech and pharma clients globally and drive better patient outcomes across all phases of clinical trials.
More info >>

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>




©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement